Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Journal of Biopharmaceutical Statistics|August 23, 2016
Flexible shrinkage estimation of subgroup effects through Dirichlet process priorsMargaret Gamalo-Siebers, Ram Tiwari, Lisa LaVange
Biometrical Journal. Biometrische Zeitschrift|December 28, 2018
The changing landscape of data monitoring committees-Perspectives from regulators, members, and sponsorsAmit Bhattacharyya, Paul Gallo, Adam Crisp, et al.
Statistics in Biopharmaceutical Research|April 3, 2023
Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials TomorrowGianna McMillan, Cristiana Mayer, Rui Tang, et al.
Nature Reviews. Drug Discovery|February 15, 2023
Application of Bayesian approaches in drug development: starting a virtuous cycleStephen J Ruberg, Francois Beckers, Rob Hemmings, et al.
Annals of Internal Medicine|June 28, 2021
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): Designing Master Protocols for Evaluation of Candidate COVID-19 TherapeuticsLisa LaVange, Stacey J Adam, Judith S Currier, et al.
The American Journal of Cardiology|January 2, 2007
Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trialsWilliam B White, Christine R West, Jeffrey S Borer, et al.
The American Journal of Psychiatry|July 13, 2013
Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorderL Fredrik Jarskog, Robert M Hamer, Diane J Catellier, et al.
American Journal of Respiratory and Critical Care Medicine|June 15, 2017
Spirometry Reference Equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos)Lisa LaVange, Sonia M Davis, John Hankinson, et al.
Pediatric Pulmonology|February 11, 2005
Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosisRobin Deterding, George Retsch-Bogart, Laura Milgram, et al.
Journal of Clinical and Translational Science|October 31, 2024
Preparing better: Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) therapeutics trials lessons learned: A call to the futureStacey J Adam, Timothy G Buchman, Judith S Currier, et al.
Pageof 3